相关实验视频

Updated: Jun 17, 2025

Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults

Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults

Published on: April 22, 2022

结构-活性关系和多醇对丁氧化酶的抑制的变化:一篇综述

Kexin Li¹, Yumei Wang¹, Wanlu Liu¹

¹Key Laboratory of Geriatric Nutrition and Health, Beijing Technology and Business University, Beijing 100048, China.

Foods (Basel, Switzerland)

|August 10, 2024

概括

黄类药物可以通过抑制丁氧化还原酶 (XOR) 来降低高尿酸水平. 它们的结构,特别是基和平面基,增强了这种效应,而糖基化减少了它. 处理可以改善他们的活动.

科学领域:

生物化学生物化学
药理学药理学是指药理学的学科.
营养科学营养科学

背景情况:

超尿血症 (HUA),以血尿酸升高为特征,越来越常见.
聚醇,特别是黄类,对丁氧化还原酶 (XOR) 具有显著的抑制作用,这是尿酸生产中的关键酶.
了解类黄的结构-活性关系 (SAR) 对于开发有效的HUA治疗至关重要.

研究的目的:

审查抑制XOR活性的黄类药物的SAR.
分析黄酸的结构性质和与XOR残留物的相互作用如何影响抑制潜力.
探索提取,加工和消化如何影响多XOR抑制活性.

主要方法:

文献综述侧重于检查黄类结构和XOR抑制的研究.
对参与与黄类抑制剂结合的关键XOR残留物的分析.
评估结构修改 (例如,基,甲基,糖化) 对黄类活性的影响.
在加工和消化过程中对多稳定性和活性变化的研究.

主要成果:

对XOR的黄类抑制活性与氧,甲氧和平面结构正相关.
黄酸盐的糖化显著降低了它们的XOR抑制能力.
在加工过程中胃肠道消化和热处理可以增强多的XOR抑制潜力.
在结构相似的多和与氨醇之间的协同效应显示出有希望.

结论:

黄质结构是XOR抑制的关键决定因素,用于管理高尿血.
优化多结构和考虑加工效应可以提高它们的治疗效果.
对于新的HUA疗法,需要进一步研究聚醇和诸如阿洛普林醇之类的药物的协同作用组合.

关键词:

消化消化消化消化聚醇是一种多的化合物.处理处理处理处理结构活动关系结构活动关系有协同效应的效应.亚丁氧化降解酶 (xanthine oxidoreductase) 是一种可以减少亚酸的药物.

更多相关视频

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures

Published on: March 28, 2017

Extraction and Purification of Polyphenols from Freeze-dried Berry Powder for the Treatment of Vascular Smooth Muscle Cells In Vitro

Extraction and Purification of Polyphenols from Freeze-dried Berry Powder for the Treatment of Vascular Smooth Muscle Cells In Vitro

Published on: July 5, 2017

相关概念视频

Oxidation of Phenols to Quinones

Oxidation of Phenols to Quinones

In the presence of oxidizing agents, phenols are oxidized to quinones. Quinones can be easily reduced back to phenols using mild reducing agents. The electron-donating hydroxyl group enhances the reactivity of the aromatic ring, enabling oxidation of the ring even in the absence of an α hydrogen.
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox...

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...

Indirect-Acting Cholinergic Agonists: Mechanism of Action

Indirect-Acting Cholinergic Agonists: Mechanism of Action

Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...

Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems

Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems

Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...